Favorite  |  Set Home
Products > Cell Cycle > PLK > SBE13 Hydrochloride
Product name : SBE13 Hydrochloride
Item : c2372
Price : 200mg, $950;500mg, $1695; 1g, $2490; 2g, $3590
contact : Send inquiry to: info@acesobio.com
CAS : 1052532-15-6
Molecular Weight : 442.93518
Formula : C24H27ClN2O4
Storage : at -20°C
Additional information : We offer significant discount for bulky quantity order.
 Enlarge Image                   Back
             [Next Product]→


Details:
Description of:SBE13 Hydrochloride
SBE13 Hydrochloride(cas:1052532-15-6)is a potent and selective Plk1 inhibitor, with an IC50 of 200 pM; poorly inhibits Plk2 (IC50>66 μM) or Plk3 (IC50=875 nM).

Quality control data:
Quality control by 1H-NMR, 13C-NMR, HPLC and LCMS.
Product will be shipped with supporting analytical data. 

REFERENCES

1: Eckerdt F. Polo-like kinase 1 inhibitors SBE13 and BI 2536 induce different responses in primary cells. Cell Cycle. 2011 Apr 1;10(7):1027-8. Epub 2011 Apr 1. PubMed PMID: 21415595.
2: Posern G. Should I stall or should I cycle? An inhibitor for Polo-like Kinase 1 with distinct roles in primary cells. Cell Cycle. 2011 Apr 1;10(7):1029-30. Epub 2011 Apr 1. PubMed PMID: 21412046.
3: Keppner S, Proschak E, Schneider G, Spänkuch B. Fate of primary cells at the G1/S boundary after polo-like kinase 1 inhibition by SBE13. Cell Cycle. 2011 Feb 15;10(4):708-20. Epub 2011 Feb 15. PubMed PMID: 21301227.
4: Eckerdt F. Freezing Polo in its sleep: targeting the inactive conformation of Polo-like kinase 1 in cancer cells. Cell Cycle. 2010 Mar 1;9(5):862. Epub 2010 Mar 1. PubMed PMID: 20348843.
5: Keppner S, Proschak E, Kaufmann M, Strebhardt K, Schneider G, Spänkuch B. Biological impact of freezing Plk1 in its inactive conformation in cancer cells. Cell Cycle. 2010 Feb 15;9(4):761-73. Epub 2010 Feb 16. PubMed PMID: 20139717.
6: Liu X. SBE13 joins the family of Polo-like kinase 1 (Plk1) inhibitors. Cell Cycle. 2010 Feb 1;9(3):445-6. Epub 2010 Feb 1. PubMed PMID: 20130451.
7: Keppner S, Proschak E, Schneider G, Spänkuch B. Identification and validation of a potent type II inhibitor of inactive polo-like kinase 1. ChemMedChem. 2009 Nov;4(11):1806-9. doi: 10.1002/cmdc.200900338. PubMed PMID: 19746360.


Related Products :
BI 2536
BI 2536
Price: 200mg, $950;500mg, $1595; 1g $2390; 2g, $3590
ON 01910
ON 01910
Price: 200mg, $1250;500mg, $2090; 1g $2995; 2g, $4395
BI 6727 (Volasertib)
BI 6727 (Volasertib)
Price: 200mg, $750;500mg, $1190; 1g $1890; 2g, $2995
GSK 461364
GSK 461364
Price: 200mg, $750;500mg, $1190; 1g $1890; 2g, $2995
NMS-1286937
NMS-1286937
Price: 200mg, $950;500mg, $1695; 1g, $2490; 2g, $3590
TAK 960
TAK 960
Price: 200mg, $950;500mg, $1595; 1g $2390; 2g, $3590
HMN 214 (IVX 214)
HMN 214 (IVX 214)
Price: 200mg, $950;500mg, $1595; 1g $2390; 2g, $3590